March 5, 2021 Environ, Ag./Food & Bev Life Science Tools

Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc.’s (NASDAQ: ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously as a medical device. Both of these in vitro diagnostic (IVD)-ready solutions are available to customers and third-party developers to create diagnostic solutions using the technology.... Read more

March 4, 2021 Atomic Spectroscopy Environ, Ag./Food & Bev Lab Top-10

Danaher To Present At Barclays Global Healthcare Conference

WASHINGTON, March 4, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 11:30 a.m. ET. The audio will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a global science and technology innovator... Read more

March 4, 2021 Uncategorized

MTS Shareholders Approve Merger with Amphenol

EDEN PRAIRIE, Minn., March 4, 2021 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC) (“MTS”) today announced that, based on the preliminary voting results from a special meeting of shareholders held today, MTS’ shareholders have approved the adoption of the previously announced merger agreement relating to the proposed transaction between MTS and Amphenol Corporation (NYSE: APH)... Read more

March 4, 2021 Uncategorized

Qiagen N.V. – Login

This site is protected by Two-Factor Authentication. Please download Google Authenticator from the App Store for iOS or the Play Store for Android. For other devices, download an authenticator app from your device store.View more detail Set up your Google Authenticator account by scanning the QR code or adding the secret key below. Enter the... Read more

March 4, 2021 Acad, Gov/Utilities Liq. Handling & Robotics PR/Corporate

Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2 Mar 04, 2021 6:30 AM EST Provides labs with high throughput, syndromic respiratory testing capabilities AUSTIN, Texas, March 4, 2021... Read more

March 3, 2021 Clinical Research/Diagn. Product Launch

QIAGEN launches QIAsphere cloud-based connectivity solution to enhance QIAstat-Dx capabilities in digital diagnostics

Hilden, Germany, and Germantown, Maryland, March 3, 2021 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has launched its QIAsphere cloud-based platform that will allow labs and QIAstat-Dx users to monitor tests and instrument status remotely 24 hours a day, 7 days a week. QIAsphere sets new standards for syndromic testing digital health, providing users with... Read more

March 3, 2021 Lab Top-10

Thermo Scientific Spectra Ultra Offers a Leap Forward for Advanced Materials Characterization

Thermo Scientific Spectra Ultra Offers a Leap Forward for Advanced Materials Characterization All-in-one (S)TEM enables the understanding of complex samples for materials scientists and semiconductor manufacturers HILLSBORO, Ore., March 3, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today unveiled the Thermo Scientific Spectra Ultra, a next-generation scanning transmission electron microscope... Read more

March 2, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock... Read more

March 2, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock... Read more